Robotic Minimally Invasive Inguinal Hernia Repair Post-Market Clinical Study With the DEXTER Robotic System
Condition(s) studied
Investigational drug(s) / intervention(s)
inguinal hernia repair: Robotic-assisted inguinal hernia repair with the DEXTER robotic surgery system
Study summary
The purpose of this post-market, observational study is to collect data under anticipated conditions of use that demonstrates that DEXTER performs as intended in the intended patient population, including a variety of representative disease etiologies and demographic groups.
Eligibility
Primary outcome measure(s)
- Primary safety outcome — up to 30 days after surgery
Occurrence of Clavien-Dindo grades III-V adverse events - Primary efficacy outcome — Intraoperative
Successful completion of the DEXTER-assisted procedure, i.e. free of any conversion to an open or fully laparoscopic surgical approach
Trial sites (2)
| Facility | City | Region | Status |
|---|---|---|---|
| Northtowns Ambulatory Surgical Center (NASC) | Buffalo | New York | Recruiting |
| Memorial Hermann-Texas Medical Center - UT Health Houston | Houston | Texas | Recruiting |
More Distalmotion SA trials in the USA
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07181876 on ClinicalTrials.gov ↗ ← All trials in the USA